Coronary Atherosclerosis: Current Management and Treatment addresses the leading cause of death worldwide—coronary artery disease. Atherosclerosis has a broad range of disease manifestations depending on the degree of the stenosis, and the functional status of the coronary plaque and is a disease cardiologists manage every day. Prevalence of coronary artery disease is increasing as a greater number of people live longer and rising rates of obesity contribute to poor health.
This brand new title, written by a leading international team of editors, addresses the pathophysiology of disease, established and novel diagnostic approaches (both invasive and non-invasive), treatment methodologies (including treatment algorithms), and differing perspectives on treatment including future therapies and long-term outcomes. It includes every aspect of coronary artery disease and highlights the optimal treatment for different clinical scenarios. The inclusion of personal perspectives from key opinion leaders, full color images and ancillary video files make this a key resource.
Key topics include:
- Pharmacology of coronary artery disease (CAD)
- Up-to-date evidence on pathophysiology
- Non-invasive imaging
- Current evidence for risk stratification
- Invasive imaging/cutting-edge technology
- Clinical decision making from masters in the field
Coronary Atherosclerosis: Current Management and Treatment provides a state-of-the-art review of current knowledge to aid specialists, general physicians, and cardiologists in training, in the diagnosis, risk stratification, and management of patients with diverse presentations of coronary atherosclerosis.
Chourmouzios Arampatzis, MD, PhD,FESC, Senior Interventional Cardiologist, Interbalkan Medical Center, Thessaloniki, Greece
Eugene P. McFadden MB, BCh, BAO, DCH, MRCP(UK), FRCPI, FESC, FACC, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands and Interventional Cardiologist, Cork University Hospital, Wilton, Cork, Ireland
Lampros K. Michalis MD, Professor in Cardiology, Department of Cardiology, Medical School, University of Ioannina, Greece
Renu Virmani, M.D, President and Medical Director, CVPath Institute, Inc., Gaithersburg, Maryland, USA
Patrick W. Serruys MD, Head of the Interventional Dept., Heartcenter Rotterdam, Rotterdam, The Netherlands